The Oslo Medicines Initiative (OMI) has commissioned a series of technical reports to review and analyze the relevant evidence and provide policy considerations. Two reports were authored by an WHO…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Oslo Medicines Initiative: technical reports on innovation and transparency
Redesignation as WHO Collaborating Centre until 2026
We proudly announce that the Pharmacoeconomics Department at GÖG has been re-designated as WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies for another four years until…
Policy brief on net price transparency
What are the implications of policies increasing transparency of prices paid for pharmaceuticals? Policy action on net price transparency (NPT) for pharmaceuticals – the public disclosure of prices…